Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Knowles Julius
Director at Keros Therapeutics. Filing since 13 Apr 2020.
CIK 0001808365
Company
Date
Role
Action
Shares
Amount
Of holding
KROS
Keros Therapeutics, Inc.
4 Jun 2026
Director
Sold on a plan
2,625
$28.17K
19.3%
KROS
Keros Therapeutics, Inc.
5 Jan 2022
Director
Sold, plan not stated
4,034
$234.99K
1.7%
KROS
Keros Therapeutics, Inc.
4 Jan 2022
Director
Sold, plan not stated
20,062
$1.15M
7.9%
KROS
Keros Therapeutics, Inc.
3 Jan 2022
Director
Sold, plan not stated
23,555
$1.37M
8.9%
KROS
Keros Therapeutics, Inc.
2 Dec 2021
Director
Sold, plan not stated
25,338
$1.36M
9.2%
KROS
Keros Therapeutics, Inc.
1 Dec 2021
Director
Sold, plan not stated
22,313
$1.22M
7.9%
KROS
Keros Therapeutics, Inc.
3 Nov 2021
Director
Sold, plan not stated
15,967
$669.78K
5.6%
KROS
Keros Therapeutics, Inc.
2 Nov 2021
Director
Sold, plan not stated
7,881
$334.15K
2.8%
KROS
Keros Therapeutics, Inc.
1 Nov 2021
Director
Sold, plan not stated
23,803
$1.00M
7.8%
KROS
Keros Therapeutics, Inc.
20 Oct 2021
Director
Sold, plan not stated
4,082
$156.09K
1.4%
KROS
Keros Therapeutics, Inc.
19 Oct 2021
Director
Sold, plan not stated
4,516
$172.35K
1.5%
KROS
Keros Therapeutics, Inc.
18 Oct 2021
Director
Sold, plan not stated
13,786
$519.71K
4.5%
KROS
Keros Therapeutics, Inc.
15 Oct 2021
Director
Sold, plan not stated
8,198
$321.05K
2.7%
KROS
Keros Therapeutics, Inc.
14 Oct 2021
Director
Sold, plan not stated
4,383
$175.89K
1.4%
KROS
Keros Therapeutics, Inc.
5 Oct 2021
Director
Sold, plan not stated
2,617
$104.76K
0.9%
KROS
Keros Therapeutics, Inc.
4 Oct 2021
Director
Sold, plan not stated
3,746
$150.06K
1.2%
KROS
Keros Therapeutics, Inc.
1 Oct 2021
Director
Sold, plan not stated
6,323
$253.93K
2.0%
KROS
Keros Therapeutics, Inc.
27 Sep 2021
Director
Sold, plan not stated
95,302
$3.92M
23.6%
KROS
Keros Therapeutics, Inc.
2 Jul 2021
Director
Sold, plan not stated
23,818
$984.57K
6.4%
KROS
Keros Therapeutics, Inc.
1 Jul 2021
Director
Sold, plan not stated
23,834
$983.79K
6.3%
KROS
Keros Therapeutics, Inc.
7 Jun 2021
Director
Sold, plan not stated
12,796
$638.45K
3.4%
KROS
Keros Therapeutics, Inc.
4 Jun 2021
Director
Sold, plan not stated
6,619
$314.16K
1.8%
KROS
Keros Therapeutics, Inc.
3 Jun 2021
Director
Sold, plan not stated
7,895
$378.73K
2.1%
KROS
Keros Therapeutics, Inc.
2 Jun 2021
Director
Sold, plan not stated
11,529
$562.14K
3.0%
KROS
Keros Therapeutics, Inc.
1 Jun 2021
Director
Sold, plan not stated
8,812
$462.69K
2.3%
KROS
Keros Therapeutics, Inc.
4 May 2021
Director
Sold, plan not stated
2,835
$152.86K
0.7%
KROS
Keros Therapeutics, Inc.
3 May 2021
Director
Sold, plan not stated
44,816
$2.58M
10.4%
KROS
Keros Therapeutics, Inc.
6 Apr 2021
Director
Sold, plan not stated
9,298
$546.84K
2.3%
KROS
Keros Therapeutics, Inc.
5 Apr 2021
Director
Sold, plan not stated
27,151
$1.63M
6.3%
KROS
Keros Therapeutics, Inc.
1 Apr 2021
Director
Sold, plan not stated
11,202
$659.70K
2.6%
KROS
Keros Therapeutics, Inc.
4 Mar 2021
Director
Sold, plan not stated
11,632
$645.38K
2.7%
KROS
Keros Therapeutics, Inc.
3 Mar 2021
Director
Sold, plan not stated
12,327
$707.11K
2.8%
KROS
Keros Therapeutics, Inc.
2 Mar 2021
Director
Sold, plan not stated
10,711
$629.28K
2.4%
KROS
Keros Therapeutics, Inc.
1 Mar 2021
Director
Sold, plan not stated
12,979
$818.79K
2.9%
KROS
Keros Therapeutics, Inc.
18 Feb 2021
Director
Sold, plan not stated
2,944
$185.78K
0.7%
KROS
Keros Therapeutics, Inc.
17 Feb 2021
Director
Sold, plan not stated
16,061
$980.59K
3.5%
KROS
Keros Therapeutics, Inc.
16 Feb 2021
Director
Sold, plan not stated
9,612
$575.67K
2.1%
KROS
Keros Therapeutics, Inc.
12 Feb 2021
Director
Sold, plan not stated
7,468
$459.49K
1.6%
KROS
Keros Therapeutics, Inc.
11 Feb 2021
Director
Sold, plan not stated
11,561
$749.44K
2.5%
KROS
Keros Therapeutics, Inc.
13 Apr 2020
Director
Bought
1,191
$24.99K
opened
40 decisions on file.
